乳腺癌经济毒性研究进展(5)
[25] Hershman DL，Shao T，Kushi LH，et al. Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer [J]. Breast Cancer Res Treat，2011，126(2)：529-537.
[26] Schnipper LE，Davidson NE，Wollins DS，et al. American Society of Clinical Oncology Statement：A Conceptual Framework to Assess the Value of Cancer Treatment Options [J]. J Clin Oncol，2015，33(23)：2563-2577.
[27] Cherny NI，Sullivan R，Dafni U，et al. A standardised，generic，validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies：The European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS) [J]. Ann Oncol，2017，28(11)：2901-2905.
[28] Meropol NJ，Schrag D，Smith TJ，et al. American Society of Clinical Oncology guidance statement：The cost of cancer care [J]. J Clin Oncol，2009，27(23)：3868-3874.
[29] Tucker-Seeley RD，Yabroff KR. Minimizing the “Financial Toxicity” Associated With Cancer Care：Advancing the Research Agenda [J]. J Natl Cancer Inst，2016，108(5)：410.
[30] Kaser E，Shaw J，Marven M，et al. Communication about high-cost drugs in oncology the patient view [J]. Ann Oncol，2010，21(9)：1910-1914.
(收稿日期：2019-05-06 本文編辑：任 念), http://www.100md.com(景静凤 高晋南 李冬)
[26] Schnipper LE，Davidson NE，Wollins DS，et al. American Society of Clinical Oncology Statement：A Conceptual Framework to Assess the Value of Cancer Treatment Options [J]. J Clin Oncol，2015，33(23)：2563-2577.
[27] Cherny NI，Sullivan R，Dafni U，et al. A standardised，generic，validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies：The European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS) [J]. Ann Oncol，2017，28(11)：2901-2905.
[28] Meropol NJ，Schrag D，Smith TJ，et al. American Society of Clinical Oncology guidance statement：The cost of cancer care [J]. J Clin Oncol，2009，27(23)：3868-3874.
[29] Tucker-Seeley RD，Yabroff KR. Minimizing the “Financial Toxicity” Associated With Cancer Care：Advancing the Research Agenda [J]. J Natl Cancer Inst，2016，108(5)：410.
[30] Kaser E，Shaw J，Marven M，et al. Communication about high-cost drugs in oncology the patient view [J]. Ann Oncol，2010，21(9)：1910-1914.
(收稿日期：2019-05-06 本文編辑：任 念), http://www.100md.com(景静凤 高晋南 李冬)